Skip to main content
Article thumbnail
Location of Repository

Involvement of GTA protein NC2β in Neuroblastoma pathogenesis suggests that it physiologically participates in the regulation of cell proliferation

By Cinzia Di Pietro, Marco Ragusa, Davide Barbagallo, Laura R Duro, Maria R Guglielmino, Alessandra Majorana, Veronica Giunta, Antonella Rapisarda, Elisa Tricarichi, Marco Miceli, Rosario Angelica, Agata Grillo, Barbara Banelli, Isabella Defferari, Stefano Forte, Alessandro Laganà, Camillo Bosco, Rosalba Giugno, Alfredo Pulvirenti, Alfredo Ferro, Karl H Grzeschik, Andrea Di Cataldo, Gian P Tonini, Massimo Romani and Michele Purrello
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2005). B r i n k s c h m i d t C , C h r i s t i a n s e n H , C o m b a r e t V , L a s t o w s k a
    2. (2002). Cancer biology. A matter of dosage. Science
    3. (2006). Chiang CM: The general transcription machinery and general cofactors. Crit Rev Biochem Mol Biol
    4. (1992). CL: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA
    5. (2002). Collart MA: The NC2 alpha and beta subunits play different roles in vivo. Genes Dev
    6. (2007). Evolution, and Expression of TBPL2, a Member of the TBP Family.
    7. (2007). Filipowicz W: Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol
    8. (1996). G: Genomic localization of the human gene for NC2β, a negative modulator of transcription of class II and class III genes. Cytogenet Cell Genet
    9. (2004). Gene expression profiling of 1p35-36 genes in neuroblastoma. Oncogene
    10. (2003). Genetic and epigenetic alterations in neuroblastoma. Cancer Lett
    11. (1998). Genomics and transcription analysis of human TFIID. Oncogene
    12. (2001). Grzeschik KH: Genes For Human General Transcription Initiation Factors TFIIIB, TFIIIB-Associated Proteins, TFIIIC2 and PTF/ SNAPC: functional and positional candidates for tumour predisposition or inherited genetic diseases? Oncogene
    13. (1995). Grzeschik KH: Genetic characterization of general transcription factors TFIIF and TFIIB of Homo sapiens sapiens. Cytogenet Cell Genet
    14. (2007). Gut IG: DNA methylation analysis by pyrosequencing. Nat Prot
    15. (2008). H: Epigenetic silencing of tumour suppression gene p15 by its antisense RNA. Nature
    16. (1993). Hedborg F: Revisions of the international criteria to neuroblastoma diagnosis, staging and response to treatment.
    17. (1995). I: Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID.
    18. (2006). JM: Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res
    19. (2001). Kassavetis GA: The RNA polymerase III transcription apparatus.
    20. (2002). Leedman PJ: mRNA Stability and the Control Of Gene Expression: Implication for Human Disease. Neurochem Research
    21. (2003). Life on a planet of its own: regulation of RNA polymerase I transcription in the nucleolus. Genes Dev
    22. (2003). Merino C: The transcriptional complexity of the TFIIH complex. Trends Genet
    23. (2003). Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer
    24. (1993). Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology.
    25. (1990). Reinberg D: Factors involved in specific transcription by mammalian RNA polymerase II: role of transcription factors IIA, IID, and IIB during formation of a transcription-competent complex. Mol Cell Biol
    26. (1996). Reinberg D: Requirement of a corepressor for Dr1-mediated repression of transcription. Genes Dev
    27. (1997). Reinberg D: The Dr1/DRAP1 heterodimer is a global repressor of transcription in vivo.
    28. (1997). RG: Considerations of transcriptional control mechanisms: do TFIID-core promoter complexes recapitulate nucleosome-like functions? Proc Natl Acad Sci USA
    29. (2006). RG: Human Mediator enhances basal transcription by facilitating recruitment of transcription factor IIB during preinitiation complex assembly.
    30. (2004). SA: A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res
    31. (2006). Speleman F: Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes. Genome Biol
    32. (2005). T: MAFIA: A Maximal Frequent Itemset Algorithm.
    33. (1999). Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer
    34. (1992). TFIIB, an evolutionary link between the transcription machineries of archaebacteria and eukaryotes. Cell
    35. (2003). The eukaryotic transcriptional machinery: complexities and mechanisms unforeseen. Nat Med
    36. (1996). The human general co-factors. Trends Biochem Sci
    37. (1995). The RNA polymerase II holoenzyme and its implications for gene regulation. Trends Biochem Sci
    38. (1996). The role of general initiation factors in transcription by RNA polymerase II. Trends Biochem Sci
    39. (1993). Tibshirani RJ: An introduction to the bootstrap.
    40. (2000). Tjian R: Orchestrated response: a symphony of transcription factors for gene control. Genes Dev
    41. (2002). Tora L: Distinct mutations in yeast TAF(II)25 differentially affect the composition of TFIID and SAGA complexes as well as global gene expression patterns. Mol Cell Biol
    42. (2005). V: Long range control of gene expression: emerging mechanisms and disruption in disease.
    43. (2002). Vogelstein B, Lengauer C: The role of chromosomal instability in tumor initiation.
    44. (2000). White RJ: RNA polymerase III transcription factor TFIIIC2 is overexpressed in ovarian tumors. Proc Natl Acad Sci USA

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.